Osteoporosis, a systemic skeletal disease, is characterized by low bone mass and architectural deterioration, leading to increased bone fragility. With an aging population, the burden of osteoporosis is rising, making its effective management imperative. This article aims to outline recent advancements and existing challenges in osteoporosis management.
Recent years have seen significant advancements in osteoporosis diagnostics and therapeutics. High-resolution peripheral quantitative computed tomography (HR-pQCT) and trabecular bone score (TBS) have improved the assessment of bone quality. Therapeutically, new drugs such as Romosozumab, a monoclonal antibody, have shown promising results in increasing bone formation and decreasing bone resorption.
Despite advancements, challenges persist. Identifying individuals at risk remains difficult due to the asymptomatic nature of osteoporosis until a fracture occurs. Adherence to medication is another challenge due to side effects and the perception that osteoporosis is a natural part of aging. Furthermore, the long-term safety of new drugs is yet to be established.
Healthcare professionals play a pivotal role in managing osteoporosis. They need to educate patients about the importance of regular bone health checks, proper nutrition, and exercise. They also need to address patients' concerns about medication side effects and emphasize the necessity of adherence to treatment plans.
While advancements in osteoporosis management have improved patient outcomes, challenges persist. Healthcare professionals need to take a proactive approach in educating patients, promoting early detection, and ensuring adherence to treatment plans. As research progresses, it is hoped that the management of osteoporosis will continue to improve, reducing the burden of this debilitating disease.
1.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
2.
Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia
3.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
4.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
5.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
1.
Ferroptosis as a Therapeutic Target in Cancer
2.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
3.
Adaptive Cell Therapies for Solid Tumors
4.
Engineered Niches for Blood-Cell Regeneration: Current Concepts and Clinical Implications
5.
Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation